Charlotte K. Boughton, United Kingdom

University of Cambridge Level 4, Wellcome Trust-MRC Institute of Metabolic Science, Box 289

I am a Clinical Lecturer in Diabetes and Endocrinology at the University of Cambridge, UK and my research focuses on the use of diabetes technologies to improve outcomes for people with diabetes. I investigate the impact of hybrid closed-loop systems in children and adults with type 1 diabetes. To broaden access to technology and improve outcomes, I develop educational tools for healthcare professionals and patients to get the most out of diabetes technologies and ultimately to support adoption and reimbursement. I am also interested in using diabetes technologies, in particular closed-loop systems, to improve the safety of people with diabetes in the acute hospital setting. Our research group have undertaken randomised clinical trials to evaluate the efficacy and safety of a fully closed-loop approach for inpatients with type 2 diabetes.

Presenter of 2 Presentations

Conference Calendar

PARALLEL SESSION

Broadening usage of closed-loop

Date

Fri, 04.06.2021

Session Name

0430 - Live Q&A: Parallel Session 13: Close-Loop (2) (ID 47)

Lecture Time

20:12 - 20:32

Presenter

Charlotte K. Boughton, United Kingdom

Authors

Charlotte K. Boughton, United Kingdom

Abstract

Abstract

Abstract Body

Hybrid closed-loop systems are associated with improved glycaemic control and quality of life benefits in children and adults with type 1 diabetes. Commercially available hybrid closed-loop systems are increasingly being used as part of routine clinical diabetes care.

Disparities in clinical outcomes of type 1 diabetes are widening, and inequalities in access to diabetes technologies may perpetuate this. Closed-loop systems may provide an important opportunity to address variations in diabetes outcomes.

In this talk we review the available clinical evidence, and report on our experience of closed-loop use in patient groups where diabetes management can be particularly challenging. We will also discuss key considerations for healthcare providers to promote equitable access to closed-loop technology.

Hide

PARALLEL SESSION